01/27/2017 - 3:39pm

Citing sources close to the negotiations, The New York Post on Friday reported that private-equity giant Cerberus Capital may emerge as a possible white knight for Walgreens and Rite Aid by acquiring the 865 stores being divested. "Cerberus had participated in Walgreen’s December auction of the stores in question, losing to a winning bid of $950 million from regional drug chain Fred’s, according to two sources close to the situation," The Post reported. "Walgreens had rejected Cerberus’ bid partly because it was concerned the Federal Trade Commission would not approve a private-equity buyer, according to the sources." Either way, the deal is "not in danger of collapsing" even though the deal technically expires Friday, The Post added. (The New York Post)

01/27/2017 - 2:58pm

The new Walgreens specialty pharmacies are part of more than 250 Walgreens community and health system pharmacies that focus on community-based, patient-centered care.

01/27/2017 - 8:45am

According to the Texas Influenza Surveillance Report, for the week ending Jan. 14, the percentage of doctor and hospital visits for influenza-like illnesses appoached 6%.

01/27/2017 - 8:00am

The dividend is payable March 10, 2017 to stockholders of record as of Feb. 15, 2017.

01/26/2017 - 4:19pm

If the Walgreens-Rite Aid deal is not extended, Walgreens may need to forfeit a $325 million termination fee, analysts noted.

01/26/2017 - 10:03am

"At this time, we are actively engaged in discussion with Rite Aid regarding how to proceed," Walgreens Boots Alliance CEO Stefano Pessina told shareholders. "These discussions include taking into account anything that is required to gain approval."

01/25/2017 - 11:00am

The TD Bank-branded in-store ATM installation follows the company's expansion last summer in Boston-area Walgreens locations.

01/25/2017 - 10:41am

The New York Post late Tuesday night reported that neither Walgreens nor Rite Aid will the nix the deal if the they don't get regulatory approval by the deadline Jan. 27.  “I assume that is correct,” a source with direct knowledge of the situation told The Post on Tuesday. "Rite Aid’s shares closed up 5 cents, at $6.95, well below the offer price," The Post added. "Its shares could fall below $4 if the deal is blocked, sources said." (The New York Post)

01/23/2017 - 12:04pm

"As the Walgreens/Rite Aid merger agreement is set to expire on Jan. 27, Walgreens could look to re-cut the ... deal given the challenges, potentially enhancing its profile," noted DB analyst George Hill.